Major Biotechs See a Rising Tide of Short Interest
The July 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 127
Does Biogen Deserve More Credit for Q2 Earnings?
Biogen released better-than-expected second-quarter financial results before the markets opened on Tuesday.
Why Haliburton Is Monday’s Big Earnings Loser
Haliburton released solid second-quarter financial results before the markets opened on Monday, but there are growing concerns.
Reata Pharmaceuticals Wins Big in Kidney Study
Reata shares saw a solid gain on Monday after the company reported results from a couple midstage kidney trials.
Why LifePoint Is Surging
LifePoint Health shares made a solid gain on to start off the week after it was announced that the private equity firm Apollo Global Management would be acquiring it.
Amgen, Eli Lilly, Gilead and More Major Health Care Companies Reporting This Week
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger health care companies that are about to report their quarterly results.
6 Speculative BioHealth Analyst Stocks That Could Rally 50% to 300%
Some biotech and biohealth stocks are receiving analyst coverage calling for 50%, 100%, 200% and even 300% upside price targets. There is no assurance that these upside targets will ever be reached and some…
PTC Therapeutics Wins Big With Agilis Biotherapeutics Acquisition
PTC Therapeutics shares made a handy gain on Friday after the firm announced that it would be acquiring Agilis Biotherapeutics.
Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings
Four pharmaceutical industry leaders are poised to report second-quarter results next week, and one key analyst sees the relatively good print from Johnson & Johnson as a good signal for the group as a…
Mersana Cries for Mercy
Mersana Therapeutics shares took a massive dive on Thursday morning after the company announced that the FDA put a partial hold on the firm’s early-stage cancer study.
Rubius Therapeutics Enters the Market With a Bang
Rubius Therapeutics entered the market with a bang in its initial public offering.
Pfizer and Eli Lilly Win in Late-Stage Osteoarthitis Study
Pfizer and Eli Lilly shares were largely unaffected after the firms announced positive results from a joint late-stage trial in patients with osteoarthritis pain.
Why Voyager Therapeutics Shares Are Surging
Voyager Therapeutics shares saw a handy gain on Tuesday after the company announced that it received some feedback from the FDA.
Why UnitedHealth Earnings Aren’t Enough
UnitedHealth Group Inc. (NYSE: UNH) released its second quarter financial results before the markets opened on Tuesday. The company said that it had $3.14 in earnings per share (EPS) and $56.1 billion in revenue,…
Are Johnson & Johnson Q2 Earnings Good Enough?
Johnson & Johnson reported better-than-expected second-quarter financial results before the markets opened on Tuesday.